Document is current
Any future updates will be listed below
-
Authors
Crespo-Garcia, Sergio
Fournier, Frédérik
Diaz-Marin, Roberto http://orcid.org/0000-0003-0298-347X
Klier, Sharon
Ragusa, Derek
Masaki, Lauren
Cagnone, Gael http://orcid.org/0000-0001-9664-3518
Blot, Guillaume http://orcid.org/0000-0002-8955-6704
Hafiane, Ikhlas
Dejda, Agnieszka
Rizk, Rana
Juneau, Rachel
Buscarlet, Manuel http://orcid.org/0000-0003-1036-8100
Chorfi, Sarah
Patel, Priyanka
Beltran, Pedro J.
Joyal, Jean-Sebastien
Rezende, Flavio A.
Hata, Masayuki http://orcid.org/0000-0002-5248-5762
Nguyen, Alex
Sullivan, Lynne
Damiano, Jason
Wilson, Ariel M.
Mallette, Frédérick A.
David, Nathaniel E.
Ghosh, Anirvan
Tsuruda, Pamela R.
Dananberg, Jamie
Sapieha, Przemyslaw http://orcid.org/0000-0002-9171-2825
-
Funding
Funding for this research was provided by:
Diabetes Canada (DI-3-18-5444-PS)
Gouvernement du Canada | Canadian Institutes of Health Research (#353770)
UNITY Biotechnology
Fonds de Recherche du Québec - Santé
Montreal Diabetes Research Center
- License Information
-
More Information
Article History
Received: 27 December 2022
Accepted: 3 January 2024
First Online: 6 February 2024
Competing interests
: P.S., J. Dananberg, A.G., L.S. and A.N. are executives at UNITY Biotechnology. N.D. is the founder of UNITY Biotechnology. S.K., D.R., L.M., P.P., P.J.B., A.N., J.D., L.S. and P.R.T. were employees of UNITY Biotechnology during the time this project was developed and hold shares in the company. S.C.-G., R.D.-M., F.F., G.C., A.D., A.M.W. and J.-S.J. have contract work with UNITY Biotechnology. The other authors declare no competing interests.
